Accenture and UCB have partnered to build a safety solution based on Accenture’s INTIENT Pharmacovigilance to help accelerate processing of individual patient safety case reports. The goal is to help UCB uncover patient safety impacts from existing treatments and better manage the risks of new drugs and services.   Accenture’s INTIENT Pharmacovigilance leverages artificial intelligence to collect, manage and learn from UCB’s structured and unstructured source data within pharmacovigilance, whi...